These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 1601333

  • 1. Deoxycytidine protects normal bone marrow progenitors against Ara-C and gemcitabine cytotoxicity without compromising their activity against cisplatin-resistant human ovarian cancer cells.
    Bhalla K, Holladay C, Lutzky J, Ibrado AM, Bullock G, Jasiok M, Singh S.
    Gynecol Oncol; 1992 Apr; 45(1):32-9. PubMed ID: 1601333
    [Abstract] [Full Text] [Related]

  • 2. The interaction of gemcitabine and cytarabine on murine leukemias L1210 or P388 and on human normal and leukemic cell growth in vitro.
    Lech-Maranda E, Korycka A, Robak T.
    Haematologica; 2000 Jun; 85(6):588-94. PubMed ID: 10870114
    [Abstract] [Full Text] [Related]

  • 3. Decreased resistance to gemcitabine (2',2'-difluorodeoxycitidine) of cytosine arabinoside-resistant myeloblastic murine and rat leukemia cell lines: role of altered activity and substrate specificity of deoxycytidine kinase.
    Bergman AM, Pinedo HM, Jongsma AP, Brouwer M, Ruiz van Haperen VW, Veerman G, Leyva A, Eriksson S, Peters GJ.
    Biochem Pharmacol; 1999 Feb 15; 57(4):397-406. PubMed ID: 9933028
    [Abstract] [Full Text] [Related]

  • 4. Deoxycytidine preferentially protects normal versus leukemic myeloid progenitor cells from cytosine arabinoside-mediated cytotoxicity.
    Bhalla K, MacLaughlin W, Cole J, Arlin Z, Baker M, Graham G, Grant S.
    Blood; 1987 Aug 15; 70(2):568-71. PubMed ID: 3607288
    [Abstract] [Full Text] [Related]

  • 5. Interaction between cisplatin and gemcitabine in vitro and in vivo.
    Peters GJ, Bergman AM, Ruiz van Haperen VW, Veerman G, Kuiper CM, Braakhuis BJ.
    Semin Oncol; 1995 Aug 15; 22(4 Suppl 11):72-9. PubMed ID: 7481849
    [Abstract] [Full Text] [Related]

  • 6. Collateral sensitivity to gemcitabine (2',2'-difluorodeoxycytidine) and cytosine arabinoside of daunorubicin- and VM-26-resistant variants of human small cell lung cancer cell lines.
    Bergman AM, Munch-Petersen B, Jensen PB, Sehested M, Veerman G, Voorn DA, Smid K, Pinedo HM, Peters GJ.
    Biochem Pharmacol; 2001 Jun 01; 61(11):1401-8. PubMed ID: 11331076
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of the cytotoxic activity of gemcitabine in primary cultures of tumor cells from patients with hematologic or solid tumors.
    Csoka K, Liliemark J, Larsson R, Nygren P.
    Semin Oncol; 1995 Aug 01; 22(4 Suppl 11):47-53. PubMed ID: 7481845
    [Abstract] [Full Text] [Related]

  • 8. Delayed addition of deoxycytidine protects normal CD34+ cells against cytotoxicity of gemcitabine without compromising its activity against human leukemic cells.
    Tiefenthaler M, Hohla F, Strasser-Wozak E, Bacher N, Mühlmann O, Wein W, Konwalinka G.
    Stem Cells; 2003 Aug 01; 21(3):266-71. PubMed ID: 12743321
    [Abstract] [Full Text] [Related]

  • 9. Comparison of antineoplastic activity of 2',2'-difluorodeoxycytidine and cytosine arabinoside against human myeloid and lymphoid leukemic cells.
    Bouffard DY, Momparler LF, Momparler RL.
    Anticancer Drugs; 1991 Feb 01; 2(1):49-55. PubMed ID: 1958852
    [Abstract] [Full Text] [Related]

  • 10. Comparison of the cellular pharmacokinetics and toxicity of 2',2'-difluorodeoxycytidine and 1-beta-D-arabinofuranosylcytosine.
    Heinemann V, Hertel LW, Grindey GB, Plunkett W.
    Cancer Res; 1988 Jul 15; 48(14):4024-31. PubMed ID: 3383195
    [Abstract] [Full Text] [Related]

  • 11. Induction of resistance to 2',2'-difluorodeoxycytidine in the human ovarian cancer cell line A2780.
    Ruiz van Haperen VW, Veerman G, Eriksson S, Stegmann AP, Peters GJ.
    Semin Oncol; 1995 Aug 15; 22(4 Suppl 11):35-41. PubMed ID: 7481843
    [Abstract] [Full Text] [Related]

  • 12. [Non-clinical studies of gemcitabine--the mode of action and antitumor activities].
    Tsukagoshi S.
    Gan To Kagaku Ryoho; 1999 Feb 15; 26(3):393-400. PubMed ID: 10065109
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of protein kinase C activator-mediated induction of p21CIP1 and p27KIP1 by deoxycytidine analogs in human leukemia cells: relationship to apoptosis and differentiation.
    Vrana JA, Kramer LB, Saunders AM, Zhang XF, Dent P, Povirk LF, Grant S.
    Biochem Pharmacol; 1999 Jul 01; 58(1):121-31. PubMed ID: 10403525
    [Abstract] [Full Text] [Related]

  • 14. Sensitivity to ionizing radiation and chemotherapeutic agents in gemcitabine-resistant human tumor cell lines.
    van Bree C, Castro Kreder N, Loves WJ, Franken NA, Peters GJ, Haveman J.
    Int J Radiat Oncol Biol Phys; 2002 Sep 01; 54(1):237-44. PubMed ID: 12182997
    [Abstract] [Full Text] [Related]

  • 15. Cross-resistance in the 2',2'-difluorodeoxycytidine (gemcitabine)-resistant human ovarian cancer cell line AG6000 to standard and investigational drugs.
    Bergman AM, Giaccone G, van Moorsel CJ, Mauritz R, Noordhuis P, Pinedo HM, Peters GJ.
    Eur J Cancer; 2000 Oct 01; 36(15):1974-83. PubMed ID: 11000580
    [Abstract] [Full Text] [Related]

  • 16. Antitumor effect of the nucleoside analogs 2-chlorodeoxyadenosine and 2',2'-difluorodeoxycytidine on human hepatoma HepG2 cells.
    Graziadei I, Kelly T, Schirmer M, Geisen FH, Vogel W, Konwalinka G.
    J Hepatol; 1998 Mar 01; 28(3):504-9. PubMed ID: 9551690
    [Abstract] [Full Text] [Related]

  • 17. Molecular effects of 2',2'-difluorodeoxycytidine (Gemcitabine) on DNA replication in intact HL-60 cells.
    Ross DD, Cuddy DP.
    Biochem Pharmacol; 1994 Oct 18; 48(8):1619-30. PubMed ID: 7980627
    [Abstract] [Full Text] [Related]

  • 18. Effects of gemcitabine on cis-platinum-DNA adduct formation and repair in a panel of gemcitabine and cisplatin-sensitive or -resistant human ovarian cancer cell lines.
    Peters GJ, Van Moorsel CJ, Lakerveld B, Smid K, Noordhuis P, Comijn EC, Weaver D, Willey JC, Voorn D, Van der Vijgh WJ, Pinedo HM.
    Int J Oncol; 2006 Jan 18; 28(1):237-44. PubMed ID: 16328001
    [Abstract] [Full Text] [Related]

  • 19. In vitro studies on the immunosuppressive effect of 2',2'-difluorodeoxycytidine (dFdC) and its metabolite 2',2'-difluorodeoxyuridine (dFdU).
    Tiefenthaler M, Hohla F, Irschick E, Strasser-Wozak E, Bacher N, Mühlmann O, Wein W, Konwalinka G.
    Immunobiology; 2003 Jan 18; 207(2):149-57. PubMed ID: 12675273
    [Abstract] [Full Text] [Related]

  • 20. Effect of tetrahydrouridine and deoxytetrahydrouridine on the interaction between 2'-deoxycytidine and 1-beta-D-arabinofuranosylcytosine in human leukemia cells.
    Grant S, Bhalla K, McCrady C.
    Leuk Res; 1991 Jan 18; 15(4):205-13. PubMed ID: 2030601
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.